Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
- PMID: 16642044
- DOI: 10.1038/sj.leu.2404246
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
Abstract
In acute myeloid leukemia (AML), activating mutations in the fms-like tyrosine kinase 3 (FLT3) gene predict poor prognosis. We determined FLT3 internal tandem duplications (FLT3/ITD) and D835 point mutations in paired initial and relapse samples from 80 pediatric and adult AML patients. One D835 point mutation was found in an initial pediatric AML sample. Fms-like tyrosine kinase 3/ITDs were present in 21 initial and 22 relapse samples (26.3 and 27.5%, respectively). Interestingly, FLT3/ITD positivity was related to a significantly shorter time to relapse, most pronounced when the ITD-positive status was found at relapse (P<0.001). However, FLT3/ITD status changed between diagnosis and relapse in 14 cases. In four patients, the FLT3/ITD became undetectable at relapse in five patients FLT3/ITDs were only detected at relapse, and in five patients the length or number of FLT3/ITDs changed. Gain of FLT3/ITDs may suggest oligoclonality with selective outgrowth of the FLT3/ITD-positive clone, whereas losses may reflect ITDs in the more mature leukemic cells rather than in the leukemic stem cell, or, alternatively, that other genetic aberrations provided a greater selective advantage. Studying FLT3/ITD kinetics in minimal residual disease setting may provide some answers for the changes we observed. Fms-like tyrosine kinase 3/ITD is a relevant marker for prognosis, and remains an important target for therapeutic inhibition.
Similar articles
-
Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy.Leuk Res. 2004 Oct;28(10):1069-74. doi: 10.1016/j.leukres.2004.02.009. Leuk Res. 2004. PMID: 15289019
-
Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.Ann Hematol. 2007 Oct;86(10):741-7. doi: 10.1007/s00277-007-0325-3. Epub 2007 Jun 20. Ann Hematol. 2007. PMID: 17579862
-
Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.Ann Hematol. 2009 Nov;88(11):1089-97. doi: 10.1007/s00277-009-0733-7. Epub 2009 Mar 19. Ann Hematol. 2009. PMID: 19296110
-
Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update.Expert Rev Hematol. 2014 Apr;7(2):301-15. doi: 10.1586/17474086.2014.857596. Epub 2013 Dec 6. Expert Rev Hematol. 2014. PMID: 24308526 Review.
-
[FLT3 Mutations in Acute Myeloid Leukemia].Rinsho Byori. 2017 Jan;65(1):44-51. Rinsho Byori. 2017. PMID: 30695511 Review. Japanese.
Cited by
-
Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia.Oncotarget. 2018 Jul 10;9(53):30128-30145. doi: 10.18632/oncotarget.25729. eCollection 2018 Jul 10. Oncotarget. 2018. PMID: 30046393 Free PMC article.
-
Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives.J Clin Med. 2022 Jan 4;11(1):253. doi: 10.3390/jcm11010253. J Clin Med. 2022. PMID: 35011994 Free PMC article. Review.
-
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.J Clin Oncol. 2015 Sep 20;33(27):2949-62. doi: 10.1200/JCO.2015.62.8289. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304895 Free PMC article. Review.
-
How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?Transl Pediatr. 2013 Apr;2(2):80-3. doi: 10.3978/j.issn.2224-4336.2013.04.09. Transl Pediatr. 2013. PMID: 26835296 Free PMC article. No abstract available.
-
Gene mutations of acute myeloid leukemia in the genome era.Int J Hematol. 2013 Feb;97(2):165-74. doi: 10.1007/s12185-013-1257-4. Epub 2013 Jan 29. Int J Hematol. 2013. PMID: 23359299 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous